() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Research and Development

Earth Science Tech, Inc. (ETST) Starts Formulating a Full Spectrum Cannabinoids (CBD) Beverage Utilizing its University of Central Oklahoma Provisional Patent

DORAL, Florida, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTCQB: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today shares it has started formulating a full spectrum CBD beverage utilizing its University of Central Oklahoma Provisional Patent to improve immune system functions.
Read more

Emerald Health Therapeutics’ Subsidiary Northern Vine Receives International Government Approvals and Completes Import and Export of Cannabis Oils for Research & Development

Oct. 10, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) announced today that Northern Vine Canada Inc. (Northern Vine), a wholly owned subsidiary of Emerald, successfully completed the export of cannabis oil to the United States on May 25 pursuant to an import permit from the federal U.S. Drug Enforcement Agency (DEA). The cannabidiol (CBD)-containing cannabis oil is expected to be used by a US biopharmaceutical company to develop its proprietary cannabinoid technology for medical research and development and for its manufacturing process for future clinical trials.
Read more

Canadian Cannabis Company, The Flowr Corporation, to Begin Trading on the TSX Venture Exchange

MARKHAM, Ontario, Sept. 26, 2018 (GLOBE NEWSWIRE) -- The Flowr Corporation (TSXV: FLWR) (“Flowr” or “Company”) announced that it expects its shares to be available for trading on the TSX Venture Exchange (“Exchange”) under the symbol FLWR at market open today, September 26, 2018. This follows the recent completion by Flowr of both an oversubscribed $C36 million capital raise and reverse takeover of a capital pool company previously listed on the Exchange.
Read more
Get $50 in free trades.